Many studies have revealed that ATP4B expression is decreased in human gastric cancer (GC) [25–28], and some studies have reported abnormal expression of ATP4B in other diseases such as human hepatocellular carcinoma (HCC) [29], laryngopharyngeal reflux, and laryngeal cancer [30]. Here, ATP4B is linked to hepatocellular carcinoma.